‘Every day is brighter and better': Meghan, Duchess of Sussex shares rare photos of Lilibet in birthday post
Meghan, Duchess of Sussex
has shared rare photos of her daughter, Lilibet, to mark the princess' fourth birthday.
In one black-and-white picture, posted on
Instagram
on Wednesday, Meghan can be seen cuddling Lilibet, whose face is partially visible behind her mother's hand and arm.
'Happy birthday to our beautiful girl! Four years ago today she came into our lives – and each day is brighter and better because of it. Thanks to all of those sending love and celebrating her special day,' wrote Meghan in the caption.
A second photo in the post shows Meghan cradling Lilibet, whose face is visible in profile, shortly after her birth.
The princess was born on June 4, 2021, a year after the Duke and Duchess of Sussex stepped back from their roles as
senior royals
and moved to the
United States
.
Meghan and husband
Prince Harry
are known to fiercely guard the privacy of Lilibet and older brother Prince Archie, 6.
The couple did release a Christmas card last year that featured a rare photo of both children, but their backs are to the camera as they run towards their parents. Five other images appeared on the card, all depicting engagements from the year. It marked the first time since 2021 that Harry and Meghan released a Christmas card featuring their children.
In April, Meghan revealed that she had suffered from postpartum preeclampsia, calling the potentially fatal condition 'so rare and so scary.'
'The world doesn't know what's happening quietly,' Meghan said on the debut episode of her Confessions of a Female Founder podcast.
'And in the quiet, you're still trying to show up for people… mostly for your children, but those things are huge medical scares.'
Most cases of postpartum preeclampsia develop within 48 hours of childbirth, but it can develop four to six weeks postpartum, according to the Mayo Clinic. Postpartum preeclampsia can cause seizures and other serious complications if left untreated.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sydney Morning Herald
3 hours ago
- Sydney Morning Herald
‘Betrayal': She built a cult baby business, then RFK Jr came calling
It's a point of tension that tends to bubble up during motherhood in particular, when many parents are trying to 'figure things out on their own' and are increasingly sceptical of government institutions, said Sara Petersen, the author of Momfluenced: Inside the Maddening, Picture-Perfect World of Mommy Influencer Culture. Focusing on their child's diet and lifestyle can create 'an illusion of control' over their wellbeing. This can become a gateway of sorts into Kennedy's Make America Healthy Again movement. It isn't, in other words, a coincidence that the movement is fuelled by so-called 'crunchy' mothers. The same mothers might also be Bobbie's target customer. Complicity, or a front seat? Modi, 39, started the Bobbie brand in 2018, creating infant formula that is marketed as free from corn syrup, palm oil and other ultra-processed ingredients that have been commonplace in US formula brands. She has also thrown the brand's weight behind policies and non-profits focused on equity in maternal health, reproductive health and access to paid parental leave. This marketing strategy has differentiated Bobbie from other formula brands and generated a cult-like following. Millennial parents seem especially interested in its nutritional value and are perhaps also drawn to its social media-ready packaging, with its soft colour palette and slogans such as, 'I like it shaken, not stirred'. Modi, a mother of four, is a canny marketer, of both herself and her business. She was named one of Time's women of the year in February and one of Marie Claire's power moms in May. The company reached $US100 million ($156 million) in revenue in 2023 – making it the third-largest formula manufacturer in the United States, holding 4 per cent of that market – and is sold at Target and Whole Foods. A contingent of Bobbie's customers sees an about face in Modi's alignment with Kennedy, a man who has been accused by critics of undermining established science and promoting public health policies that they say put children's lives at risk. 'I'm genuinely sad about this,' one follower wrote on the Instagram post of Modi with Kennedy. Another customer, Allison Rhone, 43, a social media manager at a non-profit, noted that the Instagram caption lacked any context about what she called the 'craziness' of much of Kennedy's agenda. 'That to me is complicity because it makes it all seem normal,' she said. Meghan Novisky, 41, a Bobbie customer and a criminology professor at Cleveland State University, said: 'It almost felt like a betrayal; I felt shocked to see that. It just shatters my trust in them.' In interviews, others vowed never to use or recommend Bobbie again. (The company said it hadn't seen a dip in subscriptions.) But 'what's the potential outcome of not being in that room?' Modi said in an interview. 'Two things can be true at the same time,' she said. 'I don't agree with many of the things that this current administration is doing. It's very hard to watch the dismantling of really important agencies and, specifically within my world, parts of the FDA.' But, she said, she saw value in being in the room with a decision-maker like Kennedy. A 'naive' plan Modi moved from the west coast of Ireland to California for a job at Google in 2006. She planned to stay in the United States for a year or two before moving back to Ireland. Instead, she ended up climbing the corporate ladder and, in 2011, became director of hospitality at Airbnb. She assumed that she would breastfeed her first child, born in 2016, but her plans were upended by a nasty bout of mastitis, an infection of the breast. With a raging fever and a crying five-day-old infant, she walked into a Walgreens at 11pm. 'What am I picking up? What's the right thing to feed my baby?' she said of the thoughts that were racing through her mind then. 'No idea.' There were few formula brand options, and the ingredient lists on the cans were incomprehensible. She walked out that night with a pack of Similac, manufactured by Abbott, and the germ of an idea. Loading In any spare minute, Modi looked up ingredients, researched infant nutritional science and examined how the existing formula brands functioned. She asked her mother to smuggle in cans of European brands for her daughter, which, at the time, were not approved by the Food and Drug Administration to be sold in the US (an increasingly common practice for parents). The European Commission regulates formula differently, said Dr Bridget Young, a professor of paediatrics and a breastfeeding researcher at the University of Rochester. Europe, for example, 'sets limits on pesticide residues that can be in formula. We don't do that here,' she said. 'You can't, in Europe, use sucrose or table sugar,' she said. 'In the US, we don't regulate that.' Loading Europe also sets different limits for ingredients like DHA (a fatty acid believed to be essential for brain and eye development) and iron. Still, she added, the approaches to making formulas around the world are similar, and the small differences between them are marketed as large gulfs. Formulas are also among 'the safest foods made in the US', Young said. 'There's no perfect formula; there's no poison formula.' Similac, for instance – which Modi weaned her daughter off in favour of the imports – is fed to babies in hospitals, including in the neonatal intensive care unit wards. When, in December 2017, Modi found out she was pregnant again, she quit her job and decided to start Bobbie. 'In my mind,' she said, 'I'm like, 'I got nine months, I will have a better infant formula in the market before he comes.' ' That, she said, was incredibly 'naive'. For starters, there were the Goliaths of the market: the four manufacturers – Abbott, Mead Johnson (acquired by Reckitt), Nestle and Perrigo – which together controlled 97 per cent of the market in 2022. Infant formula is also highly regulated, presenting any new entrant with a labyrinth of hoops to jump through. And, infant formula being about as aspirational as antacid or Band-Aids, there were few eager investors. Most, many of whom were male, would also ask something to the effect of, ' 'Well, what are you planning to do with this?' And point to my very visible pregnant belly,' she said. By the time Modi was 8½ months pregnant, in 2018, she had pitched the idea of a 'European-style' formula to 64 investors. One gave her $US2.4 million in funding eight days before her second child arrived. It would be three more years before she would bring an FDA-approved product to market. Crises and opportunities In 2022, supply chain disruptions and a bacterial outbreak that temporarily closed Similac's plant set off a harrowing nationwide infant formula shortage. Since the brand's inception, Bobbie products had been sold online through a subscription model and were manufactured at a contract facility that also works with other smaller brands. During the shortage, when US store shelves sat bare, parents turned to Bobbie formula, creating a surge in demand that outpaced production at the contract facility. The company had to stop accepting new customers. Loading Modi bought a manufacturing facility in Ohio that began making Bobbie formula last year, allowing it to triple supply. HHS now presents Modi with another opportunity: to fulfil her long-standing goals of updating infant nutrition standards. Kennedy's MAHA agenda has many of the same talking points Modi has been espousing since 2018 – that European formulas are healthier, corn syrup in formula is a villain and regulators need to increase testing of heavy metals that have been detected in formulas made in the US. At the same time, the Trump administration has fired thousands of federal public health workers and researchers, including a committee that tracks bacterial outbreaks in infant formula. As head of the FDA division that regulates formula, Kennedy has named Kyle Diamantas, a corporate lawyer who defended Abbott in a lawsuit claiming that one of its formulas increased the risk of a deadly condition in infants. (Abbott, which lost the case, was ordered to pay $US495 million in damages.) Paediatricians worry too that, under these circumstances, a review of nutrition standards could easily veer into MAHA obsessions, like seed oils (which contain fatty acids that are essential for infant development), instead of focusing on science. Loading For Rhone, part of the appeal of Bobbie was that it was marketed as an outsider to the infant formula industry, putting it in a position to criticise the FDA and other agencies. 'I just need to know that you're going to be an actual advocate in there and that you're not just going to nod your head to whatever they're saying,' Rhone said. But to Modi, infant nutrition is a nonpartisan issue. 'And if what it takes to update nutritional standards is a certain administration, certain voices to create that change, I'm all here for it.'
The Age
3 hours ago
- The Age
‘Betrayal': She built a cult baby business, then RFK Jr came calling
It's a point of tension that tends to bubble up during motherhood in particular, when many parents are trying to 'figure things out on their own' and are increasingly sceptical of government institutions, said Sara Petersen, the author of Momfluenced: Inside the Maddening, Picture-Perfect World of Mommy Influencer Culture. Focusing on their child's diet and lifestyle can create 'an illusion of control' over their wellbeing. This can become a gateway of sorts into Kennedy's Make America Healthy Again movement. It isn't, in other words, a coincidence that the movement is fuelled by so-called 'crunchy' mothers. The same mothers might also be Bobbie's target customer. Complicity, or a front seat? Modi, 39, started the Bobbie brand in 2018, creating infant formula that is marketed as free from corn syrup, palm oil and other ultra-processed ingredients that have been commonplace in US formula brands. She has also thrown the brand's weight behind policies and non-profits focused on equity in maternal health, reproductive health and access to paid parental leave. This marketing strategy has differentiated Bobbie from other formula brands and generated a cult-like following. Millennial parents seem especially interested in its nutritional value and are perhaps also drawn to its social media-ready packaging, with its soft colour palette and slogans such as, 'I like it shaken, not stirred'. Modi, a mother of four, is a canny marketer, of both herself and her business. She was named one of Time's women of the year in February and one of Marie Claire's power moms in May. The company reached $US100 million ($156 million) in revenue in 2023 – making it the third-largest formula manufacturer in the United States, holding 4 per cent of that market – and is sold at Target and Whole Foods. A contingent of Bobbie's customers sees an about face in Modi's alignment with Kennedy, a man who has been accused by critics of undermining established science and promoting public health policies that they say put children's lives at risk. 'I'm genuinely sad about this,' one follower wrote on the Instagram post of Modi with Kennedy. Another customer, Allison Rhone, 43, a social media manager at a non-profit, noted that the Instagram caption lacked any context about what she called the 'craziness' of much of Kennedy's agenda. 'That to me is complicity because it makes it all seem normal,' she said. Meghan Novisky, 41, a Bobbie customer and a criminology professor at Cleveland State University, said: 'It almost felt like a betrayal; I felt shocked to see that. It just shatters my trust in them.' In interviews, others vowed never to use or recommend Bobbie again. (The company said it hadn't seen a dip in subscriptions.) But 'what's the potential outcome of not being in that room?' Modi said in an interview. 'Two things can be true at the same time,' she said. 'I don't agree with many of the things that this current administration is doing. It's very hard to watch the dismantling of really important agencies and, specifically within my world, parts of the FDA.' But, she said, she saw value in being in the room with a decision-maker like Kennedy. A 'naive' plan Modi moved from the west coast of Ireland to California for a job at Google in 2006. She planned to stay in the United States for a year or two before moving back to Ireland. Instead, she ended up climbing the corporate ladder and, in 2011, became director of hospitality at Airbnb. She assumed that she would breastfeed her first child, born in 2016, but her plans were upended by a nasty bout of mastitis, an infection of the breast. With a raging fever and a crying five-day-old infant, she walked into a Walgreens at 11pm. 'What am I picking up? What's the right thing to feed my baby?' she said of the thoughts that were racing through her mind then. 'No idea.' There were few formula brand options, and the ingredient lists on the cans were incomprehensible. She walked out that night with a pack of Similac, manufactured by Abbott, and the germ of an idea. Loading In any spare minute, Modi looked up ingredients, researched infant nutritional science and examined how the existing formula brands functioned. She asked her mother to smuggle in cans of European brands for her daughter, which, at the time, were not approved by the Food and Drug Administration to be sold in the US (an increasingly common practice for parents). The European Commission regulates formula differently, said Dr Bridget Young, a professor of paediatrics and a breastfeeding researcher at the University of Rochester. Europe, for example, 'sets limits on pesticide residues that can be in formula. We don't do that here,' she said. 'You can't, in Europe, use sucrose or table sugar,' she said. 'In the US, we don't regulate that.' Loading Europe also sets different limits for ingredients like DHA (a fatty acid believed to be essential for brain and eye development) and iron. Still, she added, the approaches to making formulas around the world are similar, and the small differences between them are marketed as large gulfs. Formulas are also among 'the safest foods made in the US', Young said. 'There's no perfect formula; there's no poison formula.' Similac, for instance – which Modi weaned her daughter off in favour of the imports – is fed to babies in hospitals, including in the neonatal intensive care unit wards. When, in December 2017, Modi found out she was pregnant again, she quit her job and decided to start Bobbie. 'In my mind,' she said, 'I'm like, 'I got nine months, I will have a better infant formula in the market before he comes.' ' That, she said, was incredibly 'naive'. For starters, there were the Goliaths of the market: the four manufacturers – Abbott, Mead Johnson (acquired by Reckitt), Nestle and Perrigo – which together controlled 97 per cent of the market in 2022. Infant formula is also highly regulated, presenting any new entrant with a labyrinth of hoops to jump through. And, infant formula being about as aspirational as antacid or Band-Aids, there were few eager investors. Most, many of whom were male, would also ask something to the effect of, ' 'Well, what are you planning to do with this?' And point to my very visible pregnant belly,' she said. By the time Modi was 8½ months pregnant, in 2018, she had pitched the idea of a 'European-style' formula to 64 investors. One gave her $US2.4 million in funding eight days before her second child arrived. It would be three more years before she would bring an FDA-approved product to market. Crises and opportunities In 2022, supply chain disruptions and a bacterial outbreak that temporarily closed Similac's plant set off a harrowing nationwide infant formula shortage. Since the brand's inception, Bobbie products had been sold online through a subscription model and were manufactured at a contract facility that also works with other smaller brands. During the shortage, when US store shelves sat bare, parents turned to Bobbie formula, creating a surge in demand that outpaced production at the contract facility. The company had to stop accepting new customers. Loading Modi bought a manufacturing facility in Ohio that began making Bobbie formula last year, allowing it to triple supply. HHS now presents Modi with another opportunity: to fulfil her long-standing goals of updating infant nutrition standards. Kennedy's MAHA agenda has many of the same talking points Modi has been espousing since 2018 – that European formulas are healthier, corn syrup in formula is a villain and regulators need to increase testing of heavy metals that have been detected in formulas made in the US. At the same time, the Trump administration has fired thousands of federal public health workers and researchers, including a committee that tracks bacterial outbreaks in infant formula. As head of the FDA division that regulates formula, Kennedy has named Kyle Diamantas, a corporate lawyer who defended Abbott in a lawsuit claiming that one of its formulas increased the risk of a deadly condition in infants. (Abbott, which lost the case, was ordered to pay $US495 million in damages.) Paediatricians worry too that, under these circumstances, a review of nutrition standards could easily veer into MAHA obsessions, like seed oils (which contain fatty acids that are essential for infant development), instead of focusing on science. Loading For Rhone, part of the appeal of Bobbie was that it was marketed as an outsider to the infant formula industry, putting it in a position to criticise the FDA and other agencies. 'I just need to know that you're going to be an actual advocate in there and that you're not just going to nod your head to whatever they're saying,' Rhone said. But to Modi, infant nutrition is a nonpartisan issue. 'And if what it takes to update nutritional standards is a certain administration, certain voices to create that change, I'm all here for it.'
Perth Now
7 hours ago
- Perth Now
Jessie J 'so grateful for the love and support' after breast cancer diagnosis
Jessie J has thanked her fans for their outpouring of "love and support" following her breast cancer diagnosis. The 37-year-old pop star went public with her health issues earlier this week revealing she is battling an "early" form of the disease and is currently undergoing tests before surgery later in the year - and she now has expressed her gratitude to everyone who has reached out to her since she explained her situation. In a post on Instagram, she wrote: "So grateful for all the love and support and kindness from everyone who has reached out to me in the last two days." Jessie - who is mother to two-year-old son Sky with basketball star Chanan Colman - previously revealed she was given the diagnosis prior to the release of her single, 'New Secrets' on April 25 and she has been "in and out of tests" since. She said in an Instagram video: "Before 'No Secrets' came out, I was diagnosed with early breast cancer. I'm highlighting the word 'early'. "Cancer sucks in any form but I'm holding onto the word early. I have been in and out of tests throughout this whole period." Jessie went "back and forth" with herself about whether she should share her news, due to there being "lots of opinions outside". However, the 'Who You Are' singer felt she should tell all, particularly because of the name of her latest single, 'No Secrets', which was inspired by a miscarriage she had in 2021. She said: "To get diagnosed with this, as I'm putting out a song called 'No Secrets' right before a song called 'Living My Best Life,' which was all pre-planned before I found out about this, I mean you can't make it up. "I just wanted to be open and share it - one, because, selfishly, I do not talk about it enough. "I'm not processing it because I'm working so hard. I also know how much sharing in the past has helped me, with other people giving me their love and support and also their own stories. "I'm an open book. It breaks my heart that so many people are going through so much, similar and worse. That's the bit that kills me." Jessie is still planning to perform at this year's Capital Summertime Ball on June 15 at London's Wembley Stadium, but afterwards she will undergo surgery and "disappear for a bit". She said: "It wasn't something I'd planned, but yeah. I'm getting to keep my nipples, that's good. It's a weird topic and a weird situation. "I am going to disappear for a bit after Summertime Ball to have my surgery, and I will come back with massive t*ts and more music." The 'Price Tag' hitmaker joked: "It's a very dramatic way to get a boob job."
